Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company's product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Founder

Board Member

Working at Regeneron

Overview

Regeneron jobs

Jobs

Regeneron salaries

Salary

Regeneron revenue

Revenue

Regeneron locations

Locations

Regeneron reviews

Reviews

Regeneron history

History

Regeneron demographics

Demographics

Regeneron competitors

Competitors

Regeneron CEO

CEO & Executives

Regeneron Part Time jobs

Part Time jobs

Regeneron Internships

Internships

Jobs by location

right-to-work

relocation

Regeneron Jobs locations

Jobs and salaries by city